SANAT
Phase 1 Study of Insulin Sensitivity, Adjusted β-Cell Function and Adiponectin Among Lean Drug-naïve Schizophrenic Subjects Treated With Atypical Antipsychotic Drugs
Sponsor study identifier
observational
36
1 country
1
Study Start
October 2005
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
Not reported
Date not reportedStudy Completion
February 2007
Actual (reported)The purpose of this study is to determine whether atypical antipsychotic drugs (commonly prescribed for treating schizophrenia) induce changes in anthropometry and metabolism, including alteration in insulin sensitivity and/or insulin secretion by the pancreas, when given to lean, non-diabetic, individuals who are antipsychotic drug(s)-naïve, and free of metabolic syndrome at enrollment.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
February 2007
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 2005
Date type not reportedThis date has not been verified as actual or estimated.
February 2007
Actual (reported)September 11, 2007
Actual (reported)September 12, 2007
Actual (reported)36 lean schizophrenic subjects free of metabolic syndrome(M:F 24:12; Caucasian n=23; North-African n=12; South-Asian n=1)aged 35±9 years
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
These entries preserve how the registry describes the intervention. Their treatment roles are shown separately from molecular identities.
Grouped treatment entry
quetiapine or olanzapine or risperidone or aripiprazole
The registry names several treatments. This does not confirm that participants received them together or that they form a single product.
View registry recordSanatia Hospital
Brussels, 1030, Belgium
Philippe M ORIOT, MD
Université Catholique de Louvain
36 participants (actual enrollment reported by the registry).
First Submitted
September 11, 2007
First Posted
September 12, 2007
Study Start
October 2005
Date type not reportedThis date has not been verified as actual or estimated.
Exercise and Diet Program for Schizophrenia Patients Who Are Taking Atypical Antipsychotic Medications
Contact the study team to confirm eligibility.
Study Completion
February 2007
Actual (reported)Last Updated
March 11, 2008
Record last verified: 2008-03
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: